Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07356635 · ClinicalTrials.gov registry record · NA

Cardiovascular Effects of Grieving

A NA study of Cardiovascular Health and Grief, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT07356635: Recruiting NA study of Cardiovascular Health and Grief, sponsored by University of South Florida.

NCT07356635 is a NA study of Cardiovascular Health and Grief that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 140 participants, below the 154,442-participant average among 13 other Cardiovascular Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07356635, a NA study of Cardiovascular Health and Grief, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

Self-affirmation (SA) theory proposes that people are motivated to maintain a positive self-image of being worthy, stable, and capable. Self-affirmation (SA) manipulations have been shown to effectively increase self-worth as well as reduce cardiovascular reactivity while enhancing cardiovascular recovery in response to stress. While SA is discussed as a way to alleviate grief, its effect on cardiovascular reactivity (CVR) and recovery to grief recall has yet to be studied within laboratory settings. This study proposes an experimental design to examine how an in-lab manipulation promoting self-affirmation can improve patients' cardiovascular responses during and after a grief recall procedure. The investigators hypothesized that grief severity (a continuous variable) interacts with condition (a categorical variable with two levels, i.e., SA intervention vs. control) to predict CV reactivity and recovery as outcomes. Primary Objective 1: To investigate effects of self-affirmation intervention on cardiovascular responses among grieving participants during and after grief recall. Secondary Objective 1: To investigate the relationship of grief severity with psychological stress.

Primary Outcome

A series of one-way ANCOVAs will be conducted to compare measures of cardiovascular reactivity and recovery between the self-affirmation and control conditions, controlling for gender, race, and baseline values, using a significance level of α = .05. CV reactivity will be operationalized as the difference between CV during grief recall and CV baseline measures. CV recovery will be operationalized as the difference between CV recovery measures and CV baseline measures.

Interventions

  • BEHAVIORAL Value-affirmation

Study Locations (1)

Florida

  • University of South Florida, Psychology and Communication Sciences and Disorders Lab Building - Tampa

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2025-10-16
Est. Completion 2027-03
Phase NA
University of South Florida

252 total trials

What NCT07356635 shows while recruiting

NCT07356635 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 154,442-participant average among 13 other Cardiovascular Health trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Cardiovascular Health appearing as the primary indexed condition, and to 1 intervention - of which Value-affirmation is the first listed.

NCT07356635 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07356635 about?

NCT07356635 is a clinical study titled "Cardiovascular Effects of Grieving". Self-affirmation (SA) theory proposes that people are motivated to maintain a positive self-image of being worthy, stable, and capable. Self-affirmation (SA) manipulations have been shown to effectively increase self-worth as well as reduce cardiovascular reactivity while enhancing cardiovascular re...

What is the current status of trial NCT07356635?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2025-10-16. Estimated completion is 2027-03.

What conditions does trial NCT07356635 study?

This clinical trial studies the following conditions: Cardiovascular Health, Grief, Emotion.

What interventions are being tested in trial NCT07356635?

The interventions under investigation include: Value-affirmation (BEHAVIORAL).

Who is sponsoring clinical trial NCT07356635?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07356635 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07356635's enrollment target sits among peer trials

140 5th of 13 higher than 9 of 13 other Cardiovascular Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07356635, the US trial registry maintained by the National Library of Medicine. NCT07356635 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.